[ 1 ] Kravitz BA, Corrada MM, Kawas CH. Elevated C-reactive protein levels are associated with prevalent dementia in the oldest-old[J]. Alzheimers Dement, 2009, 5(4): 318-323.
[2]
[ 2 ] Schmidt R, Schmidt H, Curb JD, et al. Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study[J]. Ann Neurol, 2002, 52(2): 168-174.
[3]
[ 3 ] Iwamoto N, Nishiyama E, Ohwada J, et al. Demonstration of CRP immunoreactivity in brains of Alzheimer’s disease: immunohistochemical study using formic acid pretreatment of tissue sections[J]. Neurosci Lett, 1994, 177(1/2): 23-26.
[4]
[ 4 ] Inestrosa NC, Godoy JA, Quintanilla RA, et al. Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration: role of Wnt signaling[J]. Exp Cell Res, 2005, 304(1): 91-104.
[ 9 ] Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies[J]. Diabetologia, 2005, 48(12): 2460-2469.
[10]
Nakano S, Kuboki K, Matsumoto T, et al. Small, dense LDL and high-sensitivity C-reactive protein (hs-CRP) in metabolic syndrome with type 2 diabetes mellitus[J]. J Atheroscler Thromb, 2010, 17(4): 410-415.
[11]
Veps？l？inen T, Soinio M, Marniemi J, et al. Physical activity, high-sensitivity C-reactive protein, and total and cardiovascular disease mortality in type 2 diabetes[J]. Diabetes Care, 2011, 34(7): 1492-1496.
[12]
Komulainen P, Lakka TA, Kivipelto M, et al. Serum high sensitivity C-reactive protein and cognitive function in elderly women[J]. Age Ageing, 2007, 36(4): 443-448.
[13]
Lin HB, Yang XM, Li TJ, et al. Memory deficits and neurochemical changes induced by C-reactive protein in rats: implication in Alzheimer’s disease[J]. Psychopharmacology (Berl), 2009, 204(4): 705-714.
[14]
Bi BT, Lin HB, Cheng YF, et al. Promotion of β-amyloid production by C-reactive protein and its implications in the early pathogenesis of Alzheimer’s disease[J]. Neurochem Int, 2012, 60(3): 257-266.
[15]
Liu F, Chen HY, Huang XR, et al. C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes[J]. Diabetologia, 2011, 54(10): 2713-2723.
Abdin AA, Baalash AA, Hamooda HE. Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers[J]. J Diabetes Complications, 2010, 24(3): 168-178.
